SYNLAB, an international medical diagnostics provider, agreed to acquire 17 healthcare centres from Gruppo Tronchet, a healthcare services provider. Financial terms were not disclosed. “With its well-established presence and high reputation as well as its broad, integrated offering, Gruppo Tronchet adds significant value to the SYNLAB network in Italy. The acquisition of Gruppo Tronchet does not only consolidate our number one position in the Italian diagnostics market. It also equips SYNLAB with great expertise allowing us to provide patients with an even more comprehensive medical offering. We are looking forward to welcoming our new colleagues to the SYNLAB family," Mathieu Floreani, SYNLAB CEO.